securities fraud

Robbins LLP files class action against Stellantis alleging investor fraud over 2025 earnings projections. Stock plunged 23.69% after €22B charge announcement.

Coty faces class-action lawsuit over allegedly misleading statements about fiscal 2026 outlook. Stock tanked after November guidance contradicted by February operational deterioration.

ODDITY Tech ($ODD) faces class action lawsuit over undisclosed algorithm changes from major ad partner that inflated customer acquisition costs, triggering 49% stock plunge.

Trip.com ($TCOM) faces securities lawsuit alleging misleading disclosure about AI pricing tool regulatory risks. Stock fell 17% after Chinese regulators opened investigation.

Class action filed against $SLNO for allegedly failing to disclose safety concerns about DCCR drug. Stock fell sharply after August 2025 short report and September patient death disclosure.

Class action lawsuit filed against $UPST for allegedly concealing AI model flaws. November reveal of weak Q3 results triggered sharp stock decline, sparking shareholder claims.

Class action lawsuit filed against $PSIX alleging false statements about data center demand and manufacturing capacity costs. Lead plaintiff deadline May 19, 2026.

Class action filed against $ALDYA alleging false statements about reproxalap trial results. Eligible investors covered Nov 2023-Mar 2026.

Eos Energy ($EOSE) faces securities fraud lawsuit after 2025 revenue of $114.2M fell far short of $150-160M guidance due to production delays.

Trip.com faces class action lawsuit alleging false regulatory risk disclosures regarding monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Nektar Therapeutics ($NKTR) faces securities fraud lawsuit after Phase 2b alopecia trial failed due to enrollment violations, triggering 7.8% stock decline.

Rosen Law Firm investigates $ELWT over financial restatement involving revenue recognition errors. Stock fell 6.8% following disclosure of adjustments to first nine months of 2025.

Trip.com faces securities fraud lawsuit following SAMR antitrust investigation into monopolistic practices. Stock declined 19.4% post-disclosure; investors have until May 2026 to join action.

Kahn Swick & Foti sues Navan for allegedly concealing 39% spike in sales/marketing expenses to $95M in Q3 2025 during October IPO. Deadline April 24, 2026.

Super Micro Computer faces DOJ indictment for allegedly diverting $2.5B in AI servers to China. Stock collapsed 33%, triggering class action lawsuits with May 26 application deadline.

ImmunityBio hit with securities fraud class action following FDA warning letter over misleading Anktiva cancer therapy ads. Stock fell 21% to $7.42.

uniQure faces securities fraud lawsuit after FDA rejection of AMT-130 data triggers 49% stock plunge from $67.69 to $34.29 on November 3, 2025.

Three companies face securities class action suits alleging material misstatements. Investors must apply by May 18, 2026 for $GEMINI; earlier deadlines for $SLNO and $NAVAN.

Law firm files class action against $ENPH for allegedly overstating inventory management and financial prospects during 2025.

Portnoy Law Firm files class action against Lakeland Industries (LAKE) alleging false statements regarding business units and operational challenges during 2023-2025 period.